Quan Vu - Dec 8, 2021 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
COO / Chief Business Officer
Signature
/s/ Quan Anh Vu
Stock symbol
ATNF
Transactions as of
Dec 8, 2021
Transactions value $
$0
Form type
4
Date filed
12/10/2021, 07:20 AM
Previous filing
Nov 4, 2021
Next filing
Dec 10, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATNF Common Stock 8K Dec 8, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNF Stock Option (Right to Buy) Award $0 +275K $0.00 275K Dec 8, 2021 Common Stock 275K $3.95 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as COO / Chief Business Officer. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.
F2 The options vest in 48 equal monthly installments, beginning on the last day of November 2021, and continuing on the last day of each calendar month thereafter, subject to the Reporting Person's continued service to the Company on such vesting dates.